Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
05.06. | Minimales Kursplus bei der Catalent-Aktie (50,5908 €) | 210 | ARIVA.de | Am US-amerikanischen Aktienmarkt ist das Wertpapier von Catalent derzeit unauffällig. Zuletzt zahlten Investoren für das Papier 54,98 US-Dollar. Wenig getan hat sich heute bislang beim Kurs von Catalent.... ► Artikel lesen | |
29.05. | Catalent, Inc. - 8-K, Current Report | 7 | SEC Filings | ||
29.05. | Catalent shareholders approve acquisition by Novo Holdings | 10 | Seeking Alpha | ||
29.05. | Catalent Stockholders Approve Deal To Be Acquired By Novo Holdings | 5 | RTTNews | ||
29.05. | Catalent stockholders approve deal with Novo Holdings | 2 | Reuters | ||
29.05. | Catalent Stockholders Approve Transaction with Novo Holdings | 91 | Business Wire | SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. ("Catalent," NYSE: CTLT), a leader in enabling the development and supply of better treatments for patients worldwide, today announced that, at its... ► Artikel lesen | |
17.05. | Siren Biotechnology, Catalent Partner for Manufacturing of AAV Gene Therapies | 7 | Contract Pharma | ||
16.05. | Catalent, Inc. - 8-K, Current Report | 4 | SEC Filings | ||
13.05. | Catalent's (CTLT) Latest Partnership to Boost Clinical Trials | 5 | Zacks | ||
09.05. | Catalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up | 6 | Zacks | ||
08.05. | Catalent Non-GAAP EPS of -$0.06 misses by $0.29, revenue of $1.07B misses by $50M | 4 | Seeking Alpha | ||
08.05. | Catalent, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
08.05. | Catalent, Inc. Reports Third Quarter Fiscal 2024 Results | 79 | Business Wire | SOMERSET, N.J.--(BUSINESS WIRE)--Catalent, Inc. (NYSE: CTLT) ("Catalent"), the leader in enabling the development and supply of better treatments for patients worldwide, today announced financial... ► Artikel lesen | |
07.05. | FTC Seeks More Information on the $16.5B Novo-Catalent Deal, Leading to Another Delay | 7 | MedCity News | ||
03.05. | Another day, another 30-day delay for Novo's Catalent acquisition as FTC imposes 'Second Request' | 24 | FiercePharma | ||
03.05. | US FTC seeks more information on Novo Nordisk parent-Catalent deal | 4 | Reuters | ||
03.05. | FTC seeks more information on Novo Holdings-Catalent deal | 6 | Reuters | ||
03.05. | Catalent, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
09.04. | Catalent, Inc. - S-8, Securities to be offered to employees in employee benefit plans | 16 | SEC Filings | ||
08.04. | Novo Nordisk parent refiles US application on Catalent deal | 362 | Reuters |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 804 |
RHEINMETALL | 483 |
TUI | 473 |
GAMESTOP | 451 |
EVOTEC | 360 |
DEUTSCHE LUFTHANSA | 355 |
NEL | 335 |
BAYER | 287 |
SNOWFLAKE | 284 |
TESLA | 272 |
BYD | 255 |
BASF | 205 |
VOLKSWAGEN | 194 |
PORSCHE SE | 180 |
DEUTSCHE TELEKOM | 179 |
APPLE | 174 |
MERCEDES-BENZ | 161 |
THYSSENKRUPP | 157 |
ALLIANZ | 148 |
DEUTSCHE BANK | 138 |
COMMERZBANK | 131 |
BROADCOM | 130 |
PLUG POWER | 128 |
MICROSOFT | 124 |
RWE | 123 |